Add Yahoo as a preferred source to see more of our stories on Google. Invivyd had also attempted to attain regulatory approval for pemivibart.Credit: Design_Cells via Shutterstock. (Design_Cells via ...

The updated NCCN Guidelines now include the recommendation for monoclonal antibodies for pre-exposure prophylaxis against COVID-19, highlighting the significance of Invivyd's products in cancer care.

LIBERTY is part of the Company’s broader REVOLUTION clinical program designed to elaborate the profile of monoclonal antibody-mediated prophylaxis from COVID-19 and the potential medical benefits to ...

Interim data captured from a phase 3 trial suggest pemivibart may be effective prophylaxis against COVID-19 infection for high-risk patients with significant immunocompromising conditions who continue ...

Emmy Award-winning journalist Paula Ebben co-anchors WBZ-TV News at 5:30 p.m. Ebben is also an anchor for CBS News Boston and reports across all newscasts including WBZ-TV News' "Eye on Education" ...

The trial expects to enrol approximately 210 participants.

Looking for information about the FDA’s limited approval of 2025-26 COVID vaccines? Read what we know about who can get an updated COVID shot this year. Updated Aug. 27 If it feels like several people ...

A new clinical trial found azelastine cut COVID-19 infections by 70%, hinting at a cheap, accessible way to add protection alongside vaccines. Let’s be honest: when it comes to COVID-19 prevention, ...

Add Yahoo as a preferred source to see more of our stories on Google. If you’re like most people in the US, you probably either know someone with COVID-19 right now, know someone who just got over an ...